Atrial fibrosis in embolic stroke of undetermined source: A multicenter study
Background and purpose Left atrial (LA) cardiac disease is a suspected cause of embolic stroke of undetermined source (ESUS). We tested the hypothesis that LA fibrosis, quantified using late‐gadolinium‐enhancement magnetic resonance imaging (LGE‐MRI), predicts recurrent stroke or atrial fibrillation...
Gespeichert in:
Veröffentlicht in: | European journal of neurology 2021-11, Vol.28 (11), p.3634-3639 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background and purpose
Left atrial (LA) cardiac disease is a suspected cause of embolic stroke of undetermined source (ESUS). We tested the hypothesis that LA fibrosis, quantified using late‐gadolinium‐enhancement magnetic resonance imaging (LGE‐MRI), predicts recurrent stroke or atrial fibrillation (AF) in patients with ESUS.
Methods
We compared atrial fibrosis in healthy controls and patients with lacunar stroke, ESUS, and known AF with or without prior stroke. We followed patients with ESUS prospectively for the primary outcome of recurrent ischemic stroke, incident AF, or both.
Results
We enrolled 203 patients from three centers: 103 patients without AF (35 healthy controls, 15 with lacunar strokes, 53 with ESUS) and 100 patients with AF (50 with and 50 without prior stroke). Patients with ESUS had significantly higher atrial fibrosis (15.0 ± 6.2%) compared to healthy controls (8.1 ± 7.9%; 12% was associated with a higher risk of recurrent stroke or incident AF. |
---|---|
ISSN: | 1351-5101 1468-1331 |
DOI: | 10.1111/ene.15022 |